Moxifloxacin Reiwa Healthcare (Moxifloxacin)

Moxifloxacin is a fluoroquinolone antibiotic used to treat bacterial infections affecting the respiratory, skin, and intra‑abdominal systems.

• Community‑acquired bacterial pneumonia: achieves bacterial eradication and clinical cure in adult patients.
• Acute bacterial sinusitis: reduces symptoms and eliminates the causative pathogens.
• Acute bacterial exacerbation of chronic bronchitis: improves lung function and shortens disease duration.
• Skin and skin structure infections: resolves infection and promotes healing of affected tissues.
• Intra‑abdominal infections: provides effective antimicrobial coverage for mixed‑organism infections.

• Moxifloxacin exerts its antibacterial activity by binding to bacterial DNA gyrase (topoisomerase II) and topoisomerase IV, enzymes essential for DNA supercoiling and replication. Inhibition of these targets prevents DNA synthesis and transcription, leading to rapid bacterial cell death. The drug displays concentration‑dependent killing and a broad spectrum against Gram‑positive, Gram‑negative, and atypical organisms.

Moxifloxacin may cause a range of adverse reactions, varying from mild to severe.

Common Side Effects

• Nausea
• Diarrhea
• Headache
• Rash

Serious or Rare Side Effects

• Tendon rupture or inflammation
• QT interval prolongation leading to arrhythmia
• Severe allergic reactions such as anaphylaxis
• Clostridioides difficile‑associated colitis

When prescribing Moxifloxacin, clinicians should consider several safety precautions to minimize risks.

• Renal impairment: monitor renal function and adjust therapy as needed.
• History of tendon disorders: avoid use due to increased risk of tendon rupture.
• Prolonged QT interval: obtain baseline ECG and avoid concomitant QT‑prolonging drugs.
• Pregnancy Category B: prescribe only when the potential benefit justifies the potential risk.
• Concurrent antacids or multivitamins containing aluminum or magnesium: separate administration by at least 2 hours to ensure absorption.
• Store at 2-8°C: keep refrigerated, protect from light, do not freeze or shake.

Moxifloxacin can interact with other medicines, altering its efficacy or safety profile.

Major Interactions (Avoid)

• Co‑administration with other fluoroquinolones: may increase toxicity without added benefit.
• Drugs that prolong the QT interval (e.g., macrolides, antiarrhythmics): heightened risk of cardiac arrhythmias.
• Concurrent use of non‑steroidal anti‑inflammatory drugs (NSAIDs): increased risk of central nervous system stimulation and seizures.

Moderate Interactions (Monitor Closely)

• Antacids containing aluminum or magnesium: reduce oral absorption; separate dosing.
• Warfarin: may enhance anticoagulant effect; monitor INR closely.
• Corticosteroids: combined use raises the chance of tendon injury.